Site icon pharmaceutical daily

Financière de Tubize – 2023 half-year financial report

Press release29 July 2023 FINANCIERE DE TUBIZE SA Allée de la Recherche 60, 1070 Brussels Contact: Eric Nys, day-to-day management, eric.nys@financiere-tubize.be 2023 half-year financial report Regulated information29 July 2023 The board of directors of Financière de Tubize has issued the 2023 half-year financial report. This report is available on the website www.financiere-tubize.be Profit for first half of 2023: € 91.1 million at 30 June 2023 (€ 87.3 million at 30 June 2022 (increase of 4.4%),Dividend received from UCB: € 93.2 million (€ 1.33 per share, an increase of 2.3% compared to the previous year),2022 Dividend paid to Financière de Tubize’s shareholders in 2023 of € 38.3 million (€ 0.86 per share, an increase of  14.7% compared to the previous year),      Acquisition, in 2023, of 649,750 UCB shares, for a total amount of € 52.0 million, at an average price of € 79.96, increasing the holding of the Company in UCB from 35.70% at 31 December 2022 to 36.04% at 30 June 2023.

Exit mobile version